Novavax clearing the way for a potential emergency approval

$Novavax(NVAX)$ This was how it was report on Hill. This is how it should've been. Not baseless assumption added articles by Politico and Reuters.

"Novavax filed final data with the Food and Drug Administration (FDA) for its COVID-19 vaccine, clearing the way for a potential emergency approval next year.

The move was the last step for the Maryland-based biotechnology company to fulfill prerequisites for its protein-based vaccine, which is different than the other three vaccines approved in the U.S. from Pfizer, Moderna and Johnson & Johnson.

If all goes well, Novavax could seek emergency approval next month as the U.S. continues to prioritize booster shots amid a spike in confirmed coronavirus cases driven by the highly transmissible omicron variant".